September 26, 2016 5:52 AM ET

Pharmaceuticals

Company Overview of Mankind Pharma Limited

Company Overview

Mankind Pharma Limited manufactures pharmaceutical products for antibiotic, antifungal, NSAIDs, gastrointestinal, anthelmintic, cardiovascular, dermal, erectile dysfunction, and other categories. It also offers contraceptive products, over-the-counter medicines, pregnancy detection cards, artificial sweeteners, and other products; and nutritional supplements, cosmetics, anti-infective tablets, anti-diabetic tablets, proton pump inhibitors, anti-allergic tablets, emergency contraceptives, anti-emetic, and other products. In addition, the company provides active pharmaceutical ingredients for various therapeutic areas, such as cardiology, respiratory, neurology, gastroenterology, diabetology, ...

236, Okhla Industrial Estate

Phase-III

New Delhi,  110 020

India

Founded in 1991

Phone:

91 11 4654 1400

Fax:

91 11 4654 1382

Key Executives for Mankind Pharma Limited

Managing Director and Director
Chief Executive Officer and Director
Whole Time Director
Age: 69
Whole Time Director
Age: 25
Vice President of Information Services & Strategy
Compensation as of Fiscal Year 2016.

Mankind Pharma Limited Key Developments

Mankind Pharma to Invest INR 1.5 Billion in Construction of Nutraceutical Factory in India

Mankind Pharma has invested some INR 1.5 billion ($23 million) on the development of a manufacturing plant in Paonta Sahib.

Two Funds Are Reportedly In Talks To Buy Mankind Stake

ChrysCapital may sell its eight-year-old investment in Mankind Pharma Limited at a price that is nearly 10 times the value of its original investment. Capital International, Inc. (Capital International Private Equity Funds) and Warburg Pincus LLC are in the final stages of negotiation with ChrysCapital to buy its 11% stake in Mankind Pharma, according to two people familiar with the development. The deal size is estimated at around $225 million-$250 million, they said. “ChrysCapital has received serious pre-emptive offers from a couple of global PE funds that have been forwarded to the Juneja family, promoters of Mankind Pharma. As Fund-IV comes to an end, it is true that ChrysCapital is in talks with the Junejas to provide an exit for their investment in Mankind latest by the end of calendar year 2015,” said Sanjiv Kaul, managing director, ChrysCapital. ChrysCapital has appointed Ernst & Young (EY) and Avendus Capital Private Limited as bankers for the transaction, according to the first person cited above. The process will be completed by August 2015-September 2015, he said. Spokespeople for Warburg Pincus and Capital International declined to comment citing company policy, reported Mint, and Mankind declined to comment on the stake sale in an email, saying the company’s “spokesperson is travelling”.

Mankind Pharma Keen to Spend INR 5 Billion for Expansion in Local Market

Mankind Pharmaceuticals is ready to invest around INT 5 billion to acquire local pharma companies in order to strengthen its presence in the domestic market. The pharma company is not the sole candidate in this race as almost all the leading Indian pharma majors are adopting the same measure for their expansion.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mankind Pharma Limited, please visit www.mankindpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.